138 related articles for article (PubMed ID: 24008413)
1. Interplay between parkin and p53 governs a physiological homeostasis that is disrupted in Parkinson's disease and cerebral cancer.
Checler F; Alves da Costa C
Neurodegener Dis; 2014; 13(2-3):118-21. PubMed ID: 24008413
[TBL] [Abstract][Full Text] [Related]
2. Parkin: much more than a simple ubiquitin ligase.
Alves da Costa C; Checler F
Neurodegener Dis; 2012; 10(1-4):49-51. PubMed ID: 22204976
[TBL] [Abstract][Full Text] [Related]
3. Glioma tumor grade correlates with parkin depletion in mutant p53-linked tumors and results from loss of function of p53 transcriptional activity.
Viotti J; Duplan E; Caillava C; Condat J; Goiran T; Giordano C; Marie Y; Idbaih A; Delattre JY; Honnorat J; Checler F; Alves da Costa C
Oncogene; 2014 Apr; 33(14):1764-75. PubMed ID: 23644658
[TBL] [Abstract][Full Text] [Related]
4. ER-stress-associated functional link between Parkin and DJ-1 via a transcriptional cascade involving the tumor suppressor p53 and the spliced X-box binding protein XBP-1.
Duplan E; Giaime E; Viotti J; Sévalle J; Corti O; Brice A; Ariga H; Qi L; Checler F; Alves da Costa C
J Cell Sci; 2013 May; 126(Pt 9):2124-33. PubMed ID: 23447676
[TBL] [Abstract][Full Text] [Related]
5. S-Nitrosylation of parkin as a novel regulator of p53-mediated neuronal cell death in sporadic Parkinson's disease.
Sunico CR; Nakamura T; Rockenstein E; Mante M; Adame A; Chan SF; Newmeyer TF; Masliah E; Nakanishi N; Lipton SA
Mol Neurodegener; 2013 Aug; 8():29. PubMed ID: 23985028
[TBL] [Abstract][Full Text] [Related]
6. [Etiology and pathogenesis of Parkinson's disease: from mitochondrial dysfunctions to familial Parkinson's disease].
Hattori N
Rinsho Shinkeigaku; 2004; 44(4-5):241-62. PubMed ID: 15287506
[TBL] [Abstract][Full Text] [Related]
7. Parkin-associated Parkinson's disease.
von Coelln R; Dawson VL; Dawson TM
Cell Tissue Res; 2004 Oct; 318(1):175-84. PubMed ID: 15503153
[TBL] [Abstract][Full Text] [Related]
8. Transcriptional repression of p53 by parkin and impairment by mutations associated with autosomal recessive juvenile Parkinson's disease.
da Costa CA; Sunyach C; Giaime E; West A; Corti O; Brice A; Safe S; Abou-Sleiman PM; Wood NW; Takahashi H; Goldberg MS; Shen J; Checler F
Nat Cell Biol; 2009 Nov; 11(11):1370-5. PubMed ID: 19801972
[TBL] [Abstract][Full Text] [Related]
9. Accumulation of the parkin substrate, FAF1, plays a key role in the dopaminergic neurodegeneration.
Sul JW; Park MY; Shin J; Kim YR; Yoo SE; Kong YY; Kwon KS; Lee YH; Kim E
Hum Mol Genet; 2013 Apr; 22(8):1558-73. PubMed ID: 23307929
[TBL] [Abstract][Full Text] [Related]
10. Lentiviral vector delivery of parkin prevents dopaminergic degeneration in an alpha-synuclein rat model of Parkinson's disease.
Lo Bianco C; Schneider BL; Bauer M; Sajadi A; Brice A; Iwatsubo T; Aebischer P
Proc Natl Acad Sci U S A; 2004 Dec; 101(50):17510-5. PubMed ID: 15576511
[TBL] [Abstract][Full Text] [Related]
11. A novel parkin-mediated transcriptional function links p53 to familial Parkinson's disease.
da Costa CA; Checler F
Cell Cycle; 2010 Jan; 9(1):16-7. PubMed ID: 20016267
[No Abstract] [Full Text] [Related]
12. Ubiquitination of a new form of alpha-synuclein by parkin from human brain: implications for Parkinson's disease.
Shimura H; Schlossmacher MG; Hattori N; Frosch MP; Trockenbacher A; Schneider R; Mizuno Y; Kosik KS; Selkoe DJ
Science; 2001 Jul; 293(5528):263-9. PubMed ID: 11431533
[TBL] [Abstract][Full Text] [Related]
13. Programmed cell death-2 isoform1 is ubiquitinated by parkin and increased in the substantia nigra of patients with autosomal recessive Parkinson's disease.
Fukae J; Sato S; Shiba K; Sato K; Mori H; Sharp PA; Mizuno Y; Hattori N
FEBS Lett; 2009 Feb; 583(3):521-5. PubMed ID: 19146857
[TBL] [Abstract][Full Text] [Related]
14. Association of DJ-1 and parkin mediated by pathogenic DJ-1 mutations and oxidative stress.
Moore DJ; Zhang L; Troncoso J; Lee MK; Hattori N; Mizuno Y; Dawson TM; Dawson VL
Hum Mol Genet; 2005 Jan; 14(1):71-84. PubMed ID: 15525661
[TBL] [Abstract][Full Text] [Related]
15. Pathologic and therapeutic implications for the cell biology of parkin.
Charan RA; LaVoie MJ
Mol Cell Neurosci; 2015 May; 66(Pt A):62-71. PubMed ID: 25697646
[TBL] [Abstract][Full Text] [Related]
16. Formation of parkin aggregates and enhanced PINK1 accumulation during the pathogenesis of Parkinson's disease.
Um JW; Park HJ; Song J; Jeon I; Lee G; Lee PH; Chung KC
Biochem Biophys Res Commun; 2010 Mar; 393(4):824-8. PubMed ID: 20171192
[TBL] [Abstract][Full Text] [Related]
17. A Splice Intervention Therapy for Autosomal Recessive Juvenile Parkinson's Disease Arising from Parkin Mutations.
Li D; Aung-Htut MT; Ham KA; Fletcher S; Wilton SD
Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33019779
[TBL] [Abstract][Full Text] [Related]
18. Evidence for a common biological pathway linking three Parkinson's disease-causing genes: parkin, PINK1 and DJ-1.
van der Merwe C; Jalali Sefid Dashti Z; Christoffels A; Loos B; Bardien S
Eur J Neurosci; 2015 May; 41(9):1113-25. PubMed ID: 25761903
[TBL] [Abstract][Full Text] [Related]
19. Parkinson's disease: assays for the ubiquitin ligase activity of neural Parkin.
Schlossmacher MG; Shimura H
Methods Mol Biol; 2005; 301():351-69. PubMed ID: 15917645
[TBL] [Abstract][Full Text] [Related]
20. Parkin gene therapy.
Mochizuki H
Parkinsonism Relat Disord; 2009 Jan; 15 Suppl 1():S43-5. PubMed ID: 19131043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
